Sarcoid-like granulomatous disease following etanercept treatment for RA.
Kudrin
Alex
A
Chilvers
Edwin R
ER
Ginawi
Amel
A
Hazleman
Brian L
BL
Griffiths
Meryl H
MH
Thiru
Sathia
S
Ostor
Andrew J K
AJ
D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001980:Bronchi / Q000473:pathology; D000068800:Etanercept; D005260:Female; D006099:Granuloma / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000473:pathology; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008206:Lymphatic Diseases / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000473:pathology; D008875:Middle Aged; D010306:Parotid Gland / Q000473:pathology*; D011859:Radiography; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D012507:Sarcoidosis / Q000139:chemically induced / Q000473:pathology
D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept